Results 1 to 10 of about 2,497,556 (305)

Benchmarks for antiretroviral therapy [PDF]

Journal of Clinical Investigation, 2000
Sharp declines in HIV-related morbidity and mortality over the last 4 years are due in part to a fuller understanding of the pathogenesis of HIV infection, the availability of sensitive assays that measure viral replication in vivo, and the use of combinations of antiretroviral drugs that profoundly suppress viral replication for prolonged periods (i.e.
O J, Cohen, A S, Fauci
openaire   +2 more sources

HIV Associated Sensory Neuropathy [PDF]

Journal of Clinical and Diagnostic Research, 2014
Background: In the era of highly active antiretroviral therapy (HAART), sensory neuropathies have increased in prevalence. We have documented the frequency and profile of the two most common forms of sensory neuropathies associated with Human ...
Amruth G, Praveen-Kumar S, Nataraju B, Nagaraja BS   +3 more
doaj   +1 more source

Hypertriglyceridemia in Antiretroviral Therapy [PDF]

Journal of the International AIDS Society, 2005
Elevated serum triglycerides, total cholesterol, very low-density lipoprotein (VLDL) cholesterol, and low-density lipoprotein (LDL) cholesterol have been reported in the literature from areas where experience with antiretroviral drugs has amassed. Up until recently the use of antiretroviral drugs in Nigeria on a wide scale was a rarity owing largely to
Imarhiagbe, Frank, Kubeyinje, Emmanuel
openaire   +3 more sources

Training needs assessment for clinicians at antiretroviral therapy clinics: evidence from a national survey in Uganda

Human Resources for Health, 2009
Background To increase access to antiretroviral therapy in resource-limited settings, several experts recommend "task shifting" from doctors to clinical officers, nurses and midwives.
Namagala Elizabeth, Lule Frank, Kaye Richard, Sebuyira Lydia, Oyugi Jessica H, Weaver Marcia R, Schneider Gisela, Lutalo Ibrahim M, Scheld W, McAdam Keith PWJ, Sande Merle A   +10 more
doaj   +1 more source

A literature review on cardiovascular risk in human immunodeficiency virus-infected patients: implications for clinical management

Brazilian Journal of Infectious Diseases, 2013
Introduction: In recent years, there has been growing concern about an increasing rate of cardiovascular diseases in human immunodeficiency virus-infected patients, which could be associated with side effects of highly active antiretroviral therapy.
Mansueto Gomes Neto, Ricardo Zwirtes, Carlos Brites   +2 more
doaj   +3 more sources

Antiretroviral Side Effects on Adherence in People Living with HIV/AIDS

Nurse Media: Journal of Nursing, 2018
Background: Antiretroviral therapy is a lifelong treatment in people living with HIV/AIDS (PLWHA). Adherence is the key to the effectiveness of antiretroviral therapy.
Gede Arya Bagus Arisudhana, Muchlis Achsan Udji Sofro, Untung Sujianto   +2 more
doaj   +1 more source

Development and validation of a composite programmatic assessment tool for HIV therapy. [PDF]

PLoS ONE, 2012
We developed and validated a new and simple metric, the Programmatic Compliance Score (PCS), based on the IAS-USA antiretroviral therapy management guidelines for HIV-infected adults, as a predictor of all-cause mortality, at a program-wide level.
Viviane D Lima, Adrian Le, Bohdan Nosyk, Rolando Barrios, Benita Yip, Robert S Hogg, P Richard Harrigan, Julio S G Montaner   +7 more
doaj   +1 more source

Antiretroviral therapy in Africa [PDF]

BMJ, 2004
We should stop and think about the risks of resistance, and ways of minimising them, before increasing access to antiretroviral therapy in Africa Demands for the introduction of antiretroviral therapy into Africa have been growing over the past few years.
Warren, Stevens, Steve, Kaye, Tumani, Corrah   +2 more
openaire   +2 more sources

Optimizing resources to reduce costs to determine HIV viral load in limited resources settings

Biomédica: revista del Instituto Nacional de Salud, 2017
Introduction: HIV viral load testing is a key factor to evaluate the accomplishment of the UNAIDS target of 90% of viral suppression among people receiving antiretroviral therapy.
Amalia Girón-Callejas, Ricardo Mendizabal-Burastero, Elizabeth Yax, Axel Martínez, Carlos Mejía-Villatoro   +4 more
doaj   +1 more source

A case report of clinical implications of a delayed antiretroviral therapy switch in a patient with multiple treatment interruptions

SAGE Open Medical Case Reports, 2022
The Namibia national antiretroviral therapy guidelines recommend that patients living with HIV who interrupt antiretrovirals and in the process disengage from care be restarted on their usual antiretroviral therapy regimen upon return.
Mireille A Mpalang Kakubu, Kandali Frans, Nelson Gibutai, Patrick DMC Katoto   +3 more
doaj   +1 more source